Ranked #1 in the World
>$40 Million in External Research Income
30 novel drug candidates
2000 undergraduate students
350 publications per year
Victorian Government Treasurer, Tim Pallas, recently visited the Monash Technology Precinct at the University’s Clayton campus where he met with the scientists behind the MMIC, an initiative dedicated to strengthening sovereign medicines
MIPS will be home to two researchers awarded close to $1M in funding through the ARC Discovery Early Career Researcher Award scheme.
Three outstanding mid-career researchers and new ARC Future Fellows, Associate Professor Darren Creek, Dr Nicholas Veldhuis and Dr Roey Elnathan have received close to $3M in funding to advance research projects addressing a range of medical needs.
Monash researchers have projected that Australia’s health budget would save approximately AUD$807 million over a five-year period if the country’s maternal health services were to offer structured diet and exercise interventions in
The federal government’s MRFF has invested almost $1 million into progressing Australian research on a combination antiviral therapy to treat COVID-19.
Australia’s healthcare resources are limited and, therefore, health interventions and therapeutics need to be shown to be cost-effective before governments and insurers will agree to provide them to, or subsidise them for, healthcare consumers.
The annual award honours an individual whose scientific contributions have had a major impact on research across all of biological chemistry.
A new study led by Monash University researchers has, for the first time, shown that the chemical compound 'nitroxyl' may represent an effective and rapid intervention for cardiovascular emergencies in type 2 diabetes.